The goals of bone tissue engineering are to apply biomaterial scaffolds with adhered cells, such as osteoblasts, bone marrow stromal stem cells, or chondrocytes, to repair, regenerate, and restore the functions of damaged bone tissue or to replace those tissues with porous engineered biomaterials. Over recent decades, a diverse class of biomaterials has been applied in bone tissue engineering field. Porous hydroxyapatite bioceramic is currently receiving significant attention as a bone tissue engineering substitute because of its biological characteristics, including biocompatibility, bioactivity, osteoconduction, and vasculogenesis. This biomaterial has a three-dimensional structure with interconnected spherical pores of uniform size, which encourages bone ingrowth and achieves good integration of the material and the host bone over time. However, the compressive strength and elastic modulus of porous hydroxyapatite scaffolds generally weaken as the porosity increases, in both in vitro and in vivo testing. Zirconia can be used to toughen hydroxyapatite materials for bone repair and replacement because of its unique biomechanical properties, including compressive strength and fracture toughness. Additionally, a zirconia chitosan hybrid containing bone morphogenetic protein-2 and mesenchymal stem cells derived from induced pluripotent stem cells has been used as a coating material adhered to surface of scaffolds to promote bone regeneration and repair. Here, we provide a succinct review of zirconia toughened hydroxyapatite biomaterial scaffolds that incorporate bone morphogenetic protein-2 and mesenchymal stem cells for bone tissue engineering and describe the biomaterials that are currently being investigated based on the recent literature and our own data.
Introduction
Bone tissue has a strong potential for regeneration after fractures or the appearance of bony defects. Autogenous bone grafting, which is biocompatible, osteoconductive, angiogenic, and has appropriate biomechanical properties and generates a minimal adverse immunologic response, remains necessary in cases of large bony defects, for conditions with poor bone-healing, and after tumor removal. Despite these advantages, several disadvantages associated with autogenous bone grafting techniques exist, such as the need for an additional surgery to harvest the appropriate size and shape grafts, and the potential risk of donor-site morbidity, which may include infection, fracture, and chronic pain. 1)4) Therefore, many types of biomaterials have been developed as bone substitutes, including bioceramics, bioactive glass, metals, and organic or non-organic bone substitutes.
5)8)
Hydroxyapatite (HA) bioceramics have been used extensively as bioactive substitute materials for bone grafts because of their biological properties, such as biocompatibility, osteoconductivity, and angiogenesis. 5),9),10) After implantation, HA bioceramics release calcium and phosphorus ions into the biomedia, and a series of biochemical reactions occur that develop strong biochemical bonds at the interface between the implanted material and the host bone, which promote bone mineralization and enhance bone regeneration. 11) Bioceramics are classified as either dense or porous, and as either granules or blocks. The porous HA materials can be tailored with different pore sizes and porosities for different types of bony defects, but their biomechanical properties are generally weak and brittle. 12) To address this, zirconia can be used to toughen the material for load-bearing applications because of its higher strength and fracture resistance compared with pure HA. 13) Furthermore, bone morphogenetic protein-2 (BMP-2) 14) and mesenchymal stem cells (MSCs) 15) have been adhered to the surface of porous HA scaffolds to improve bone ingrowth and reconstruction.
Interconnected porous HA bioceramics
HA is chemically similar to the mineral component of bone, and it supports bone growth and osteointegration when is used in orthopaedic applications. 16) However, ideal bone filler should provide a scaffold and encourage naturally forming bone to fill the voids. Engineered porous HA has been described in the literature, and it solves the common problem of such materials being too dense. 17) , 18) The surface area of porous scaffolds provides sites for the formation of chemical bonds between the bioceramics and host bone. 19) Additionally, pore size directly affects bone regeneration because the pores also provide surfaces for cell adhesion and bone tissue ingrowth. However, the interconnection of pores provides a way for cell distribution and migration, as well as vasculogenesis. 20)25) More importantly, pores that are fully interconnected are more likely to induce bone ingrowth. Yoshikawa and Myoui 17) observed that mature bone ingrowth occurred in all the pores within 6 weeks after implantation of a fully interconnected porous HA bioceramic. At 8 weeks after implantation, extensive bone volume was detected in the surface and central areas of the pores in the implants. 17) Pores with diameters greater than 100¯m may provide a framework for bone ingrowth, and later become easily vascularized. 18 ) ,26)28) However, mechanical strength decreases almost linearly with increasing porosity. 29) At one porosity, the mean compressive strength and elastic modulus of porous HA bodies were 1.04 « 0.15 MPa and 0.1 GPa, respectively. 12) These data are lower than similar values for cancellous bone, which shows 212 MPa compressive strength and 0.3 GPa elastic modulus. Therefore, the bioceramics made of calcium orthophosphates possess poor mechanical properties that prevent their use in load-bearing areas. 30) 
Zirconia toughened porous HA bioceramic
Increasing attention over the last few decades in the field of bioceramics has been paid to Zirconia (ZrO 2 ) because of its relatively high fracture toughness. 31) Based on a review of the literature, zirconia toughened materials present strong biomechanical performances, with bending strength and fracture toughness approximately ten times that of HA. 32) In contrast, the mechanical strength was reduced by a large margin after increasing the fraction of HA and increasing the porosity. 33) For human compact bone, the bending strength is 50150 MPa, the compressive strength is 100230 MPa, the fracture toughness is 26 MPam
, and the modulus of elasticity is 730 GPa. The mechanical strength of the HA/ZrO 2 composite is superior to that of human compact bone, suggesting its use should be considered as a substitute material for human compact bone. 34) Furthermore, another study showed that the dissolution rate of the HA/ZrO 2 composite was slower than of pure HA in simulated body fluid.
35)
Additionally, in vitro and in vivo tests have indicated that the zirconia toughened apatite composite bodies are fully biocompatible. The tissue reaction is healthy, and there are no reported adverse reactions with the muscular or boney-tissues at the interfaces. 36) Cytotoxicity and hemolysis assay results indicated that the HA/ZrO 2 composite had minimal toxicity and acceptable blood compatibility. 37) Therefore, the HA/ZrO 2 bioceramic offers a secure and robust system to engineer synthetic bone graft substitutes and tissue engineering scaffolds.
iPSC-derived MSCs seeded in porous HA/ZrO 2 composites
Human mesenchymal stem cells (hMSCs) are multipotent, and can be isolated from areas such as bone marrow (BM), muscle, and umbilical cord tissues. 38) Adult autologous mesenchymal stem cells (MSCs) are a promising candidate for tissue replacement therapies, and are used in clinical orthopaedics 39) because they can differentiate along the osteogenic pathway. 40 ),41) According to reports in the literature, composites of culture-expanded bone marrow mesenchymal cells combined with porous HA bioceramics have demonstrated osteogenic potential by showing ectopic bone formation in the pore areas of HA bioceramics. 42 ), 43) However, the methods for obtaining target cells for isolating MSCs are often invasive and painful, and are limited by time, place, and the availability of tissues. Furthermore, the proliferation ability of MSCs decreases with donor age.
Human induced pluripotent stem cells (iPSCs) are similar to human embryonic stem cells (ESCs) in terms of pluripotency, colony formation, and growth properties, but are not restricted by ethical problems or immunological rejection. 44) iPSCs are generated by reprogramming human somatic cells, such as adult human fibroblasts, 45) primary hepatocytes, 46) and neural stem cells, 47) and somatic cells from other areas. 48)50) However, the iPSCs that resemble ESCs may be triggering teratoma formation. Thus, it is necessary to drive the iPSC maturation into mesenchymal progenitors to use them for bone tissue engineering. 51) Several studies have confirmed the feasibility of differentiation iPSCs into MSCs in vitro. 52)54) These reports indicate that the MSC-like cells derived from both the YK26-iPSCs and H9-hECs display similar surface antigen profiles. These progenitor cells have been successfully differentiated along three different lineages: osteogenic, chondrogenic, and adipogenic. 52) 5. Porous HA/ZrO 2 bioceramic with an adsorbed xerogel-chitosan hybrid embedded with BMP-2
Recombinant human BMP-2 (rhBMP-2) was approved by the FDA for spinal fusion in 2002, which promoted the rapid development of BMP in the field of orthopaedics. At present, more than 15 different BMPs have been identified in the BMP family. BMP-2, which demonstrates the most potent osteoinductive and osteogenic properties, is widely accepted as the most important BMP growth factor for promoting bone regeneration, and is very efficient at inducing bone repair and spinal fusion, as confirmed in animal and clinical studies. 55)57) For example, Lee et al. 58) implanted porous TCP/HA adsorbed with rhBMP-2 into a calvarial defect model in Sprague Dawley rats. The results showed excellent bony tissue ingrowth at 4 weeks and bone regeneration into the porous bioceramics. With implants made from bioceramics alone, most of the tissue in the pores of the material was connective tissue at 4 weeks, and poor osteanagenesis was observed at 8 weeks after implantation. Some studies have found that new bone formation depends on the dose of BMP-2.
59) When BMP-2 is adhered to porous HA bioceramics, the porous structure of the bioceramics likely contributes to the release of BMP-2 into the surrounding tissues and biomedia. However, BMP-2 has a short biological half-life, degrading too quickly to achieve the satisfying biological effects on human bone regeneration when bolus injected. It is often released in a high initial burst if the release rate is not controlled, preventing it from achieving its expected osteogenic capacity. 60) Especially in large bony defects where the repair and regeneration might take a considerable amount of time, the slow and continuous release of BMP-2 is extraordinarily important. However, if the times or doses of implantation are increased, the side effects and expense are exacerbated. 61)63) To overcome this difficulty, a number of scientists have attempted to design better systems for the sustained release and delivery of BMP-2 by controlling its release rate.
64)70)
Chitosan is a deacetylated derivative of the natural polysaccharide chitin, which has been widely used in the biomedical field because of its biological compatibility, degradability, and osteoconductivity. 64) 68) It has been used as a coating layer on various materials to control the release of BMP-2, prolong the duration of BMP-2 release, and promote osseointegration. In one report, BMP-2 was continuously released from a silica xerogelchitosan hybrid coating layer on a porous HA scaffold for up to 6 weeks. 14) Therefore, this chitosan hybrid material has been used as a carrier for BMP-2 to control the manner and duration of release to improve its osteogenic ability and to accelerate bone defect repair.
Conclusions and perspectives
This article reviewed the present state and outlook for research and development of HA bioceramic in the field of bone tissue Shao et al.: Porous hydroxyapatite bioceramics in bone tissue engineering: current uses and perspectives engineering. Over recent decades, advances in porous HA bioceramics have been made, which can be divided into four phases.
(1) The 3D porous HA bioceramics, by virtue of their appropriate physical, chemical and biological properties, were used to repair, regenerate, and restore or replace the functions of defective bone tissues. However, the compressive strength and Young's modulus of the porous HA bioceramics both decreased with increasing pore size and porosity. (2) Zirconia, which demonstrates excellent biocompatibility and sufficient bending strength and fracture toughness, was used as a reinforcing material via coating technologies. (3) MSCs, multipotent progenitor cells that can differentiate along several cell lineages including osteoblasts and chondrocytes, were identified. MSCs were derived successfully from iPSCs generated by reprogramming human somatic cells. (4) BMP-2, as the most effective growth-factor in the BMP family, plays an important role in inducing MSC differentiation into osteoblasts, accelerating bone repair and reconstruction. However, BMP-2 typically degrades rapidly and is deactivated by enzymes and other reactions. Therefore, a chitosan hybrid material was developed as a delivery vehicle to control and sustain the release of BMP-2.
